Community Oncology Alliance shared a post on LinkedIn:
“CAR T’s approval a decade ago promised to transform cancer treatment. But administering this T-cell treatment requires substantial upfront investment. How can independent community practices ensure patients can access CAR T near where they live and work?
Experts at the 2026 Community Oncology Conference shared that a full spectrum approach to offering CAR T-including
- rigorous patient selection
- reimagined reimbursement policies
- infrastructure investment
can help practices build a sustainable system.
AJMC – The American Journal of Managed Care recaps how independent practices’ pioneering spirit delivers CAR T to patients.”
Explore the latest news featuring Community Oncology Alliance.